These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 24948413)
1. The effect of perhexiline on myocardial protection during coronary artery surgery: a two-centre, randomized, double-blind, placebo-controlled trial. Drury NE; Howell NJ; Calvert MJ; Weber RJ; Senanayake EL; Lewis ME; Hyde JA; Green DH; Mascaro JG; Wilson IC; Graham TR; Rooney SJ; Viant MR; Freemantle N; Frenneaux MP; Pagano D; Eur J Cardiothorac Surg; 2015 Mar; 47(3):464-72. PubMed ID: 24948413 [TBL] [Abstract][Full Text] [Related]
2. Multicentre double-blind randomized controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery. Senanayake EL; Howell NJ; Ranasinghe AM; Drury NE; Freemantle N; Frenneaux M; Oelofse T; Green D; Wilson IC; Rooney SJ; Mascaro J; Graham TR; Bhudia S; Lewis M; Pagano D Eur J Cardiothorac Surg; 2015 Sep; 48(3):354-62. PubMed ID: 25538197 [TBL] [Abstract][Full Text] [Related]
3. Doxycycline reduces cardiac matrix metalloproteinase-2 activity but does not ameliorate myocardial dysfunction during reperfusion in coronary artery bypass patients undergoing cardiopulmonary bypass. Schulze CJ; Castro MM; Kandasamy AD; Cena J; Bryden C; Wang SH; Koshal A; Tsuyuki RT; Finegan BA; Schulz R Crit Care Med; 2013 Nov; 41(11):2512-20. PubMed ID: 23928836 [TBL] [Abstract][Full Text] [Related]
4. Myocardial protection using fructose-1,6-diphosphate during coronary artery bypass graft surgery: a randomized, placebo-controlled clinical trial. Riedel BJ; Gal J; Ellis G; Marangos PJ; Fox AW; Royston D Anesth Analg; 2004 Jan; 98(1):20-29. PubMed ID: 14693576 [TBL] [Abstract][Full Text] [Related]
6. A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. Mullis-Jansson SL; Argenziano M; Corwin S; Homma S; Weinberg AD; Williams M; Rose EA; Smith CR J Thorac Cardiovasc Surg; 1999 Jun; 117(6):1128-34. PubMed ID: 10343261 [TBL] [Abstract][Full Text] [Related]
7. Isoflurane preconditioning-induced cardio-protection in patients undergoing coronary artery bypass grafting. Lee MC; Chen CH; Kuo MC; Kang PL; Lo A; Liu K Eur J Anaesthesiol; 2006 Oct; 23(10):841-7. PubMed ID: 16507192 [TBL] [Abstract][Full Text] [Related]
8. L-carnitine decreases myocardial injury in children undergoing open-heart surgery: A randomized controlled trial. El Feky W; El-Afify D; Abdelhai D; Elkashlan M; Fakhreldin A; El Amrousy D Eur J Pediatr; 2024 Jun; 183(6):2783-2789. PubMed ID: 38568244 [TBL] [Abstract][Full Text] [Related]
9. Effect of metformin pretreatment on myocardial injury during coronary artery bypass surgery in patients without diabetes (MetCAB): a double-blind, randomised controlled trial. El Messaoudi S; Nederlof R; Zuurbier CJ; van Swieten HA; Pickkers P; Noyez L; Dieker HJ; Coenen MJ; Donders AR; Vos A; Rongen GA; Riksen NP Lancet Diabetes Endocrinol; 2015 Aug; 3(8):615-23. PubMed ID: 26179504 [TBL] [Abstract][Full Text] [Related]
10. Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Prabhu A; Sujatha DI; Kanagarajan N; Vijayalakshmi MA; Ninan B Ann Vasc Surg; 2009; 23(5):645-51. PubMed ID: 19467834 [TBL] [Abstract][Full Text] [Related]
11. Sevoflurane versus propofol for myocardial protection in patients undergoing coronary artery bypass grafting surgery: a meta-analysis of randomized controlled trials. Yao YT; Li LH Chin Med Sci J; 2009 Sep; 24(3):133-41. PubMed ID: 19848312 [TBL] [Abstract][Full Text] [Related]
12. Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery. van Diepen S; Mehta RH; Leimberger JD; Goodman SG; Fremes S; Jankowich R; Heringlake M; Anstrom KJ; Levy JH; Luber J; Nagpal AD; Duncan AE; Argenziano M; Toller W; Teoh K; Knight JD; Lopes RD; Cowper PA; Mark DB; Alexander JH J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2302-2309.e6. PubMed ID: 31358329 [TBL] [Abstract][Full Text] [Related]
13. The Effect of High-Dose Vitamin C on Biochemical Markers of Myocardial Injury in Coronary Artery Bypass Surgery. Emadi N; Nemati MH; Ghorbani M; Allahyari E Braz J Cardiovasc Surg; 2019 Dec; 34(5):517-524. PubMed ID: 31719005 [TBL] [Abstract][Full Text] [Related]
14. Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial. Nguyen LS; Squara P; Amour J; Carbognani D; Bouabdallah K; Thierry S; Apert-Verneuil C; Moyne A; Cholley B Crit Care; 2018 Aug; 22(1):193. PubMed ID: 30115103 [TBL] [Abstract][Full Text] [Related]
15. Myocardial Protection by Glucose-Insulin-Potassium in Moderate- to High-Risk Patients Undergoing Elective On-Pump Cardiac Surgery: A Randomized Controlled Trial. Ellenberger C; Sologashvili T; Kreienbühl L; Cikirikcioglu M; Diaper J; Licker M Anesth Analg; 2018 Apr; 126(4):1133-1141. PubMed ID: 29324494 [TBL] [Abstract][Full Text] [Related]
16. The use of exogenous creatine phosphate for myocardial protection in patients undergoing coronary artery bypass surgery. Cisowski M; Bochenek A; Kucewicz E; Wnuk-Wojnar AM; Morawski W; Skalski J; Grzybek H J Cardiovasc Surg (Torino); 1996 Dec; 37(6 Suppl 1):75-80. PubMed ID: 10064355 [TBL] [Abstract][Full Text] [Related]
17. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. El-Hamamsy I; Stevens LM; Carrier M; Pellerin M; Bouchard D; Demers P; Cartier R; Page P; Perrault LP J Thorac Cardiovasc Surg; 2007 Jan; 133(1):7-12. PubMed ID: 17198774 [TBL] [Abstract][Full Text] [Related]
18. A randomized, blinded trial of the antioxidant pegorgotein: no reduction in neuropsychological deficits, inotropic drug support, or myocardial ischemia after coronary artery bypass surgery. Butterworth J; Legault C; Stump DA; Coker L; Hammon JW; Troost BT; Royster RL; Prough DS J Cardiothorac Vasc Anesth; 1999 Dec; 13(6):690-4. PubMed ID: 10622650 [TBL] [Abstract][Full Text] [Related]
19. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Candilio L; Malik A; Ariti C; Barnard M; Di Salvo C; Lawrence D; Hayward M; Yap J; Roberts N; Sheikh A; Kolvekar S; Hausenloy DJ; Yellon DM Heart; 2015 Feb; 101(3):185-92. PubMed ID: 25252696 [TBL] [Abstract][Full Text] [Related]
20. Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study). Caruba T; Hourton D; Sabatier B; Rousseau D; Tibi A; Hoffart-Jourdain C; Souag A; Freitas N; Yjjou M; Almeida C; Gomes N; Aucouturier P; Djadi-Prat J; Menasché P; Chatellier G; Cholley B J Cardiothorac Surg; 2016 Aug; 11(1):127. PubMed ID: 27496105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]